MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 215 filers reported holding MEDICINES CO in Q1 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $51,000 | -100.0% | 603 | -100.0% | 0.00% | -100.0% |
| Q3 2019 | $468,701,000 | +18.4% | 9,374,022 | -13.6% | 0.06% | +21.7% |
| Q2 2019 | $395,911,000 | +29.1% | 10,855,802 | -1.1% | 0.05% | +24.3% |
| Q1 2019 | $306,729,000 | +44.6% | 10,974,207 | -0.9% | 0.04% | +27.6% |
| Q4 2018 | $212,058,000 | -35.9% | 11,079,326 | +0.1% | 0.03% | -21.6% |
| Q3 2018 | $331,066,000 | -17.6% | 11,068,729 | +1.2% | 0.04% | -19.6% |
| Q2 2018 | $401,556,000 | +10.9% | 10,941,590 | -0.5% | 0.05% | +7.0% |
| Q1 2018 | $362,093,000 | +21.1% | 10,992,526 | +0.5% | 0.04% | +22.9% |
| Q4 2017 | $298,952,000 | -25.9% | 10,934,594 | +0.4% | 0.04% | -28.6% |
| Q3 2017 | $403,584,000 | -1.9% | 10,895,911 | +0.7% | 0.05% | -3.9% |
| Q2 2017 | $411,460,000 | -21.4% | 10,825,038 | +1.1% | 0.05% | -23.9% |
| Q1 2017 | $523,575,000 | +45.3% | 10,707,056 | +0.8% | 0.07% | +39.6% |
| Q4 2016 | $360,412,000 | -8.6% | 10,619,098 | +1.6% | 0.05% | -9.4% |
| Q3 2016 | $394,440,000 | +13.0% | 10,451,531 | +0.7% | 0.05% | +10.4% |
| Q2 2016 | $349,014,000 | +7.6% | 10,378,028 | +1.7% | 0.05% | +6.7% |
| Q1 2016 | $324,303,000 | -14.7% | 10,207,826 | +0.3% | 0.04% | -11.8% |
| Q4 2015 | $380,199,000 | +10.8% | 10,182,093 | +12.7% | 0.05% | +4.1% |
| Q3 2015 | $343,036,000 | +817.9% | 9,036,792 | +591.9% | 0.05% | +880.0% |
| Q2 2015 | $37,370,000 | +11.9% | 1,306,170 | +9.6% | 0.01% | +25.0% |
| Q1 2015 | $33,400,000 | -22.6% | 1,192,000 | -23.5% | 0.00% | -33.3% |
| Q4 2014 | $43,134,000 | -56.4% | 1,558,876 | -64.8% | 0.01% | -53.8% |
| Q3 2014 | $98,948,000 | -25.5% | 4,433,137 | -3.0% | 0.01% | -27.8% |
| Q2 2014 | $132,818,000 | +16.1% | 4,570,462 | +13.5% | 0.02% | +12.5% |
| Q1 2014 | $114,408,000 | +20.2% | 4,025,608 | +63.4% | 0.02% | +23.1% |
| Q4 2013 | $95,163,000 | +38.7% | 2,464,098 | +20.4% | 0.01% | +18.2% |
| Q3 2013 | $68,601,000 | +148.6% | 2,046,570 | +128.2% | 0.01% | +120.0% |
| Q2 2013 | $27,592,000 | – | 897,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|